Search - tctmd.com

Displaying 1 - 20 of 82

Sort: Relevancy | Date

News Daily News

Isolated Tricuspid Valve Surgery Remains Rare and Risky

Caitlin E. Cox

December 13, 2017

News Conference News TCT 2017

For ‘Torrential’ Tricuspid Regurgitation, Two New Transcatheter Devices Safe, Effective in Early Results

Yael L. Maxwell

November 02, 2017

Presentation TCT 2017

Winner Announcement

Presenter: Juan F. Granada, Tony Das, Peter J. Fitzgerald, Eberhard Grube, Grzegorz L. Kaluza, Martin B. Leon, Frank Litvack, Chaim S. Lotan, Marvin J. Slepian

November 02, 2017

Presentation TCT 2017

FORMA: 30-Day Outcomes of Transcatheter TV Repair in Patients With Severe Secondary Tricuspid Regurgitation

Presenter: Martin B. Leon, Susheel K. Kodali

November 02, 2017

Presentation TCT 2017

TRI-REPAIR: 30-Day Outcomes of Transcatheter TV Repair in Patients With Severe Secondary Tricuspid Regurgitation

Presenter: Martin B. Leon, Georg Nickenig

November 02, 2017

News Conference News TCT 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Michael O'Riordan

November 02, 2017

Presentation TCT 2017

SENIOR and Shorter DAPT Studies: Highlights Summary

Presenter: Martin B. Leon, Marco Valgimigli, Olivier Varenne

November 01, 2017

Presentation TCT 2017

CULPRIT-SHOCK: Appreciation and Critique

Presenter: Martin B. Leon, Marco Valgimigli, Cindy L. Grines

November 01, 2017

Presentation TCT 2017

CULPRIT-SHOCK: Highlights Summary

Presenter: Martin B. Leon, Marco Valgimigli, Georg Fuernau, MD

November 01, 2017

Presentation TCT 2017

CULPRIT-SHOCK: Highlights Summary

Presenter: Martin B. Leon, Marco Valgimigli, Georg Fuernau, MD

November 01, 2017

Presentation TCT 2017

ABSORB II 4-Year, ABSORB III 3-Year, ABSORB IV 30-Day: Appreciation and Critique

Presenter: Martin B. Leon, Marco Valgimigli, Giulio G. Stefanini

November 01, 2017

Presentation TCT 2017

ABSORB II 4-Year, ABSORB III 3-Year, ABSORB IV 30-Day: Highlights Summary

Presenter: Martin B. Leon, Marco Valgimigli, Gregg W. Stone

November 01, 2017

Presentation TCT 2017

Commentary II At What Point Does the Minimalist Strategy Become Ludicrous?

Presenter: Martin B. Leon

November 01, 2017

Presentation TCT 2017

Flash Debate: If I Could Only Have One Transcatheter Therapy for Mitral Regurgitation - Make It Transfemoral Mitral Valve Replacement!

Presenter: Samir R. Kapadia, Karl-Heinz Kuck, Martin B. Leon

October 31, 2017

Presentation TCT 2017

The Global Landscape of TAVR Newcomers

Presenter: Jeffrey J. Popma, John G. Webb, Martin B. Leon

October 31, 2017

Presentation TCT 2017

Transcatheter Mitral Valve Replacement Device Trials: Regulatory Approval Trial Design Considerations

Presenter: Steven F. Bolling, John C Laschinger, Martin B. Leon

October 31, 2017

Presentation TCT 2017

FDA Perspectives on TAVR Label Expansion Using Real-World Evidence, Valve Degeneration, and Embolic Protection Devices

Presenter: Martin B. Leon, Changfu Wu, John C Laschinger

October 31, 2017

Presentation TCT 2017

Valve Degeneration and Leaflet Mobility Considerations: Assessing Clinical Relevance

Presenter: Martin B. Leon, Changfu Wu, Lars Sondergaard

October 31, 2017

Presentation TCT 2017

Embolic Protection Devices For TAVR Procedures: Lessons Learned From SENTINEL and Other Experiences

Presenter: Martin B. Leon, Changfu Wu

October 31, 2017

Presentation TCT 2017

Industry Perspective on Real-World Evidence for TAVR Outcomes Where are the Opportunities?

Presenter: Martin B. Leon, Changfu Wu, Larry L. Wood

October 31, 2017

Advertisement

Isolated Tricuspid Valve Surgery Remains Rare and Risky

For ‘Torrential’ Tricuspid Regurgitation, Two New Transcatheter Devices Safe, Effective in Early Results

Winner Announcement

FORMA: 30-Day Outcomes of Transcatheter TV Repair in Patients With Severe Secondary Tricuspid Regurgitation

TRI-REPAIR: 30-Day Outcomes of Transcatheter TV Repair in Patients With Severe Secondary Tricuspid Regurgitation

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

SENIOR and Shorter DAPT Studies: Highlights Summary

CULPRIT-SHOCK: Appreciation and Critique

CULPRIT-SHOCK: Highlights Summary

CULPRIT-SHOCK: Highlights Summary

ABSORB II 4-Year, ABSORB III 3-Year, ABSORB IV 30-Day: Appreciation and Critique

ABSORB II 4-Year, ABSORB III 3-Year, ABSORB IV 30-Day: Highlights Summary

Commentary II At What Point Does the Minimalist Strategy Become Ludicrous?

Flash Debate: If I Could Only Have One Transcatheter Therapy for Mitral Regurgitation - Make It Transfemoral Mitral Valve Replacement!

The Global Landscape of TAVR Newcomers

Transcatheter Mitral Valve Replacement Device Trials: Regulatory Approval Trial Design Considerations

FDA Perspectives on TAVR Label Expansion Using Real-World Evidence, Valve Degeneration, and Embolic Protection Devices

Valve Degeneration and Leaflet Mobility Considerations: Assessing Clinical Relevance

Embolic Protection Devices For TAVR Procedures: Lessons Learned From SENTINEL and Other Experiences

Industry Perspective on Real-World Evidence for TAVR Outcomes Where are the Opportunities?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content